NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.63M | 12.24M | 12.69M | 13.29M | 14.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.82M | 56.10M | 57.62M | 60.31M | 63.86M |
| Operating Income | -38.82M | -56.10M | -57.62M | -60.31M | -63.86M |
| Income Before Tax | -42.75M | -54.66M | -55.84M | -58.01M | -60.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.75 | -54.66 | -55.84 | -58.01 | -60.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.75M | -54.66M | -55.84M | -58.01M | -60.93M |
| EBIT | -38.82M | -56.10M | -57.62M | -60.31M | -63.86M |
| EBITDA | -37.37M | -54.29M | -55.43M | -57.82M | -61.20M |
| EPS Basic | -10.27 | -18.75 | -21.58 | -24.19 | -25.91 |
| Normalized Basic EPS | -5.82 | -11.72 | -13.49 | -15.12 | -16.20 |
| EPS Diluted | -10.27 | -18.75 | -21.58 | -24.19 | -25.91 |
| Normalized Diluted EPS | -5.82 | -11.72 | -13.49 | -15.12 | -16.20 |
| Average Basic Shares Outstanding | 17.21M | 14.27M | 11.37M | 9.72M | 9.37M |
| Average Diluted Shares Outstanding | 17.21M | 14.27M | 11.37M | 9.72M | 9.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |